Sonnet BioTherapeutics requested an animation to help explain how their Fully Human Albumin Binding (FHAB) platform functions and the potential benefits of the platform over existing anti-tumor therapies. With vivid colors and key lighting details, the FHAB is clearly the star of the show in this animation. FHAB binds to the natively occurring and abundant protein albumin in the bloodstream. The bound albumin-FHAB then travels to and accumulates in inflamed tissues, including tumors. The animation takes us on the journey from FHAB introduction into the body all the way to the tumor cells, with stops along the way at the neonatal Fc receptor on the normal blood vessel wall, the Gp60 receptor found on tumor blood vessel walls, and the SPARC proteins that are found abundantly in the tumor microenvironment. At just about 2:45, this animation length has enough time to give proper visual treatment and voice over explanation of the science for viewers to fully grasp the platform.